“Repository corticotropin injection (H.P. Acthar gel) for the treatment of sarcoidosis-induced hypercalciuria and vitamin D dysregulation: A pilot, open label study” (2018) Sarcoidosis, Vasculitis and Diffuse Lung Diseases, 35(3), pp. 192–197. doi:10.36141/svdld.v35i3.6917.